1-(1-methyl-1H-1,2,4-triazol-5-yl)-1-propanone, 95.0%, 5g

[(cyclopropylmethyl)sulfinyl]acetic acid, 95.0%, 1g

TERT-BUTYL 3-METHYL-5-NITRO-1H-INDAZOLE-1-CARBOXYLATE, 95.0%, 1g

2,4-Dichloro-5-pyrimidinecarboxylic acid, 95.0%, 1g

1,2,3,4-Tetrahydronaphthalene-1-carbonitrile, 95.0%, 100g

Methyl 4-bromo-5-methoxythiophene-2-carboxylate, 97%, 1g

{1-[(furan-2-yl)methyl]-2-methanesulfonyl-1H-imidazol-5-yl}methanol, 95.0%, 10g

tert-Butyl (R)-2-(2-hydroxyethyl)piperazine-1-carboxylate, 97%, 1g

rEGCase I assisted by Activator II1vial

1-(2,4-Difluorophenyl)propan-2-one, 97.0%, 1g

2-AMINOOXAZOLE-5-CARBOXAMIDE, 95%, 250mg

4-Bromo-2,3-dichlorobenzaldehyde, 95%, 250mg

tert-Butyl (2-chloro-4-formylpyridin-3-yl)carbamate, 95+%, 1g